Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vimoktayon, Torsak
RECOVER, NCT04470544: Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19	Completed	2	100	US	Camostat Mesilate, Foipan, Standard of Care	Alan Bryce	Severe Acute Respiratory Syndrome	12/21	01/22
NCT05655819: A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia	Recruiting	1/2	30	US	Glutamine, Placebo	David J. Cangemi	Functional Dyspepsia	12/24	12/24
Cangemi, David
NCT05655819: A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia	Recruiting	1/2	30	US	Glutamine, Placebo	David J. Cangemi	Functional Dyspepsia	12/24	12/24
NCT05836597: Functional Dyspepsia Treatment Using Virtual Reality	Recruiting	N/A	30	US	Virtual reality	Mayo Clinic	Functional Dyspepsia	06/25	06/25